Business Description
Ryman Healthcare Ltd
NAICS : 623110
ISIN : NZRYME0001S4
Share Class Description:
NZSE:RYM: Ordinary SharesCompare
Compare
Traded in other countries / regions
RYM.New ZealandRH7.GermanyRYHTY.USA IPO Date
1999-06-29Description
Ryman Healthcare develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Most of its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 6.45 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.75 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.9 | |||||
| 3-Year EBITDA Growth Rate | 29 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | 24.3 | |||||
| 3-Year Book Growth Rate | 16.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.27 | |||||
| 9-Day RSI | 36.59 | |||||
| 14-Day RSI | 36.11 | |||||
| 6-1 Month Momentum % | -19.89 | |||||
| 12-1 Month Momentum % | -14.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 2.48 | |||||
| Cash Ratio | 0.1 | |||||
| Days Sales Outstanding | 437.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -1.5 | |||||
| 3-Year Average Share Buyback Ratio | -8.9 | |||||
| Shareholder Yield % | 13.6 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -0.65 | |||||
| Net Margin % | 41.29 | |||||
| FCF Margin % | 79.99 | |||||
| ROE % | 5.71 | |||||
| ROA % | 2 | |||||
| ROIC % | -0.06 | |||||
| ROC (Joel Greenblatt) % | 12.79 | |||||
| ROCE % | 2.8 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.54 | |||||
| Forward PE Ratio | 19.12 | |||||
| PE Ratio without NRI | 10.09 | |||||
| Shiller PE Ratio | 5.49 | |||||
| Price-to-Owner-Earnings | 10.25 | |||||
| PEG Ratio | 0.96 | |||||
| PS Ratio | 4.1 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.61 | |||||
| Price-to-Free-Cash-Flow | 4.96 | |||||
| Price-to-Operating-Cash-Flow | 3.27 | |||||
| EV-to-EBIT | 15.7 | |||||
| EV-to-Forward-EBIT | -77.87 | |||||
| EV-to-EBITDA | 13.69 | |||||
| EV-to-Forward-EBITDA | 25.82 | |||||
| EV-to-Revenue | 8.79 | |||||
| EV-to-Forward-Revenue | 8.18 | |||||
| EV-to-FCF | 10.99 | |||||
| Price-to-Projected-FCF | 0.33 | |||||
| Price-to-DCF (Earnings Based) | 0.66 | |||||
| Price-to-DCF (FCF Based) | 0.36 | |||||
| Price-to-Median-PS-Value | 0.23 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.79 | |||||
| Price-to-Graham-Number | 0.52 | |||||
| Earnings Yield (Greenblatt) % | 6.37 | |||||
| FCF Yield % | 17.01 | |||||
| Forward Rate of Return (Yacktman) % | 21.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Ryman Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NZ$) | 606.848 | ||
| EPS (TTM) (NZ$) | 0.404 | ||
| Beta | 1.44 | ||
| Volatility % | 33.25 | ||
| 14-Day RSI | 36.11 | ||
| 14-Day ATR (NZ$) | 0.096422 | ||
| 20-Day SMA (NZ$) | 4.4335 | ||
| 12-1 Month Momentum % | -14.15 | ||
| 52-Week Range (NZ$) | 4.12 - 6.99 | ||
| Shares Outstanding (Mil) | 687.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ryman Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ryman Healthcare Ltd Stock Events
| Event | Date | Price(NZ$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ryman Healthcare Ltd Frequently Asked Questions
What is Ryman Healthcare Ltd(NZSE:RYM)'s stock price today?
The current price of NZSE:RYM is NZ$4.26. The 52 week high of NZSE:RYM is NZ$6.99 and 52 week low is NZ$4.12.
When is next earnings date of Ryman Healthcare Ltd(NZSE:RYM)?
The next earnings date of Ryman Healthcare Ltd(NZSE:RYM) is 2024-05-17 Est..
Does Ryman Healthcare Ltd(NZSE:RYM) pay dividends? If so, how much?
Ryman Healthcare Ltd(NZSE:RYM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers